Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Sep 1;350(Pt 2):353–359.

Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases.

C A Beeton 1, E M Chance 1, L C Foukas 1, P R Shepherd 1
PMCID: PMC1221261  PMID: 10947948

Abstract

Growth factors regulate a wide range of cellular processes via activation of the class-Ia phosphoinositide 3-kinases (PI 3-kinases). We directly compared kinetic properties of lipid- and protein-kinase activities of the widely expressed p110alpha and p110beta isoforms. The lipid-kinase activity did not display Michaelis-Menten kinetics but modelling the kinetic data demonstrated that p110alpha has a higher V(max) and a 25-fold higher K(m) for PtdIns than p110beta. A similar situation occurs with PtdIns(4,5)P(2), because at low concentration of PtdIns(4,5)P(2) p110beta is a better PtdIns(4,5)P(2) kinase than p110alpha, although this is reversed at high concentrations. These differences suggest different functional roles and we hypothesize that p110beta functions better in areas of membranes containing low levels of substrate whereas p110alpha would work best in areas of high substrate density such as membrane lipid rafts. We also compared protein-kinase activities. We found that p110beta phosphorylated p85 to a lower degree than did p110alpha. We used a novel peptide-based assay to compare the kinetics of the protein-kinase activities of p110alpha and p110beta. These studies revealed that, like the lipid-kinase activity, the protein-kinase activity of p110alpha has a higher K(m) (550 microM) than p110beta (K(m) 8 microgM). Similarly, the relative V(max) towards peptide substrate of p110alpha was three times higher than that of p110beta. This implies differences in the rates of regulatory autophosphorylation in vivo, which are likely to mean differential regulation of the lipid-kinase activities of p110alpha and p110beta in vivo.

Full Text

The Full Text of this article is available as a PDF (185.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alessi D. R., Downes C. P. The role of PI 3-kinase in insulin action. Biochim Biophys Acta. 1998 Dec 8;1436(1-2):151–164. doi: 10.1016/s0005-2760(98)00133-7. [DOI] [PubMed] [Google Scholar]
  2. Anderson R. G. The caveolae membrane system. Annu Rev Biochem. 1998;67:199–225. doi: 10.1146/annurev.biochem.67.1.199. [DOI] [PubMed] [Google Scholar]
  3. Asano T., Kanda A., Katagiri H., Nawano M., Ogihara T., Inukai K., Anai M., Fukushima Y., Yazaki Y., Kikuchi M. p110beta is up-regulated during differentiation of 3T3-L1 cells and contributes to the highly insulin-responsive glucose transport activity. J Biol Chem. 2000 Jun 9;275(23):17671–17676. doi: 10.1074/jbc.M910391199. [DOI] [PubMed] [Google Scholar]
  4. Bartlett S. E., Reynolds A. J., Tan T., Heydon K., Hendry I. A. Differential mRNA expression and subcellular locations of PI3-kinase isoforms in sympathetic and sensory neurons. J Neurosci Res. 1999 Apr 1;56(1):44–53. doi: 10.1002/(SICI)1097-4547(19990401)56:1<44::AID-JNR6>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
  5. Beeton C. A., Das P., Waterfield M. D., Shepherd P. R. The SH3 and BH domains of the p85alpha adapter subunit play a critical role in regulating class Ia phosphoinositide 3-kinase function. Mol Cell Biol Res Commun. 1999 May;1(2):153–157. doi: 10.1006/mcbr.1999.0124. [DOI] [PubMed] [Google Scholar]
  6. Bi L., Okabe I., Bernard D. J., Wynshaw-Boris A., Nussbaum R. L. Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase. J Biol Chem. 1999 Apr 16;274(16):10963–10968. doi: 10.1074/jbc.274.16.10963. [DOI] [PubMed] [Google Scholar]
  7. Brown R. A., Domin J., Arcaro A., Waterfield M. D., Shepherd P. R. Insulin activates the alpha isoform of class II phosphoinositide 3-kinase. J Biol Chem. 1999 May 21;274(21):14529–14532. doi: 10.1074/jbc.274.21.14529. [DOI] [PubMed] [Google Scholar]
  8. Carpenter C. L., Auger K. R., Duckworth B. C., Hou W. M., Schaffhausen B., Cantley L. C. A tightly associated serine/threonine protein kinase regulates phosphoinositide 3-kinase activity. Mol Cell Biol. 1993 Mar;13(3):1657–1665. doi: 10.1128/mcb.13.3.1657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Carpenter C. L., Duckworth B. C., Auger K. R., Cohen B., Schaffhausen B. S., Cantley L. C. Purification and characterization of phosphoinositide 3-kinase from rat liver. J Biol Chem. 1990 Nov 15;265(32):19704–19711. [PubMed] [Google Scholar]
  10. Christoforidis S., Miaczynska M., Ashman K., Wilm M., Zhao L., Yip S. C., Waterfield M. D., Backer J. M., Zerial M. Phosphatidylinositol-3-OH kinases are Rab5 effectors. Nat Cell Biol. 1999 Aug;1(4):249–252. doi: 10.1038/12075. [DOI] [PubMed] [Google Scholar]
  11. Dhand R., Hiles I., Panayotou G., Roche S., Fry M. J., Gout I., Totty N. F., Truong O., Vicendo P., Yonezawa K. PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. EMBO J. 1994 Feb 1;13(3):522–533. doi: 10.1002/j.1460-2075.1994.tb06290.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Domin J., Waterfield M. D. Using structure to define the function of phosphoinositide 3-kinase family members. FEBS Lett. 1997 Jun 23;410(1):91–95. doi: 10.1016/s0014-5793(97)00617-0. [DOI] [PubMed] [Google Scholar]
  13. Frevert E. U., Kahn B. B. Differential effects of constitutively active phosphatidylinositol 3-kinase on glucose transport, glycogen synthase activity, and DNA synthesis in 3T3-L1 adipocytes. Mol Cell Biol. 1997 Jan;17(1):190–198. doi: 10.1128/mcb.17.1.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Funaki M., Katagiri H., Kanda A., Anai M., Nawano M., Ogihara T., Inukai K., Fukushima Y., Ono H., Yazaki Y. p85/p110-type phosphatidylinositol kinase phosphorylates not only the D-3, but also the D-4 position of the inositol ring. J Biol Chem. 1999 Jul 30;274(31):22019–22024. doi: 10.1074/jbc.274.31.22019. [DOI] [PubMed] [Google Scholar]
  15. Hiles I. D., Otsu M., Volinia S., Fry M. J., Gout I., Dhand R., Panayotou G., Ruiz-Larrea F., Thompson A., Totty N. F. Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell. 1992 Aug 7;70(3):419–429. doi: 10.1016/0092-8674(92)90166-a. [DOI] [PubMed] [Google Scholar]
  16. Hope H. R., Pike L. J. Phosphoinositides and phosphoinositide-utilizing enzymes in detergent-insoluble lipid domains. Mol Biol Cell. 1996 Jun;7(6):843–851. doi: 10.1091/mbc.7.6.843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hu P., Mondino A., Skolnik E. Y., Schlessinger J. Cloning of a novel, ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85. Mol Cell Biol. 1993 Dec;13(12):7677–7688. doi: 10.1128/mcb.13.12.7677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Katagiri H., Asano T., Ishihara H., Inukai K., Shibasaki Y., Kikuchi M., Yazaki Y., Oka Y. Overexpression of catalytic subunit p110alpha of phosphatidylinositol 3-kinase increases glucose transport activity with translocation of glucose transporters in 3T3-L1 adipocytes. J Biol Chem. 1996 Jul 19;271(29):16987–16990. doi: 10.1074/jbc.271.29.16987. [DOI] [PubMed] [Google Scholar]
  19. Kurosu H., Maehama T., Okada T., Yamamoto T., Hoshino S., Fukui Y., Ui M., Hazeki O., Katada T. Heterodimeric phosphoinositide 3-kinase consisting of p85 and p110beta is synergistically activated by the betagamma subunits of G proteins and phosphotyrosyl peptide. J Biol Chem. 1997 Sep 26;272(39):24252–24256. doi: 10.1074/jbc.272.39.24252. [DOI] [PubMed] [Google Scholar]
  20. Lam K., Carpenter C. L., Ruderman N. B., Friel J. C., Kelly K. L. The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by Wortmannin. J Biol Chem. 1994 Aug 12;269(32):20648–20652. [PubMed] [Google Scholar]
  21. Layton M. J., Harpur A. G., Panayotou G., Bastiaens P. I., Waterfield M. D. Binding of a diphosphotyrosine-containing peptide that mimics activated platelet-derived growth factor receptor beta induces oligomerization of phosphatidylinositol 3-kinase. J Biol Chem. 1998 Dec 11;273(50):33379–33385. doi: 10.1074/jbc.273.50.33379. [DOI] [PubMed] [Google Scholar]
  22. Leevers S. J., Vanhaesebroeck B., Waterfield M. D. Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr Opin Cell Biol. 1999 Apr;11(2):219–225. doi: 10.1016/s0955-0674(99)80029-5. [DOI] [PubMed] [Google Scholar]
  23. Liu Y., Casey L., Pike L. J. Compartmentalization of phosphatidylinositol 4,5-bisphosphate in low-density membrane domains in the absence of caveolin. Biochem Biophys Res Commun. 1998 Apr 28;245(3):684–690. doi: 10.1006/bbrc.1998.8329. [DOI] [PubMed] [Google Scholar]
  24. Navé B. T., Haigh R. J., Hayward A. C., Siddle K., Shepherd P. R. Compartment-specific regulation of phosphoinositide 3-kinase by platelet-derived growth factor and insulin in 3T3-L1 adipocytes. Biochem J. 1996 Aug 15;318(Pt 1):55–60. doi: 10.1042/bj3180055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rameh L. E., Cantley L. C. The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem. 1999 Mar 26;274(13):8347–8350. doi: 10.1074/jbc.274.13.8347. [DOI] [PubMed] [Google Scholar]
  26. Ricort J. M., Tanti J. F., Van Obberghen E., Le Marchand-Brustel Y. Different effects of insulin and platelet-derived growth factor on phosphatidylinositol 3-kinase at the subcellular level in 3T3-L1 adipocytes. A possible explanation for their specific effects on glucose transport. Eur J Biochem. 1996 Jul 1;239(1):17–22. doi: 10.1111/j.1432-1033.1996.0017u.x. [DOI] [PubMed] [Google Scholar]
  27. Roche S., Downward J., Raynal P., Courtneidge S. A. A function for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in fibroblasts during mitogenesis: requirement for insulin- and lysophosphatidic acid-mediated signal transduction. Mol Cell Biol. 1998 Dec;18(12):7119–7129. doi: 10.1128/mcb.18.12.7119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shepherd P. R., Withers D. J., Siddle K. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J. 1998 Aug 1;333(Pt 3):471–490. doi: 10.1042/bj3330471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Siddhanta U., McIlroy J., Shah A., Zhang Y., Backer J. M. Distinct roles for the p110alpha and hVPS34 phosphatidylinositol 3'-kinases in vesicular trafficking, regulation of the actin cytoskeleton, and mitogenesis. J Cell Biol. 1998 Dec 14;143(6):1647–1659. doi: 10.1083/jcb.143.6.1647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Stephens L. R., Eguinoa A., Erdjument-Bromage H., Lui M., Cooke F., Coadwell J., Smrcka A. S., Thelen M., Cadwallader K., Tempst P. The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. Cell. 1997 Apr 4;89(1):105–114. doi: 10.1016/s0092-8674(00)80187-7. [DOI] [PubMed] [Google Scholar]
  31. Tan H. B., Swann P. F., Chance E. M. Kinetic analysis of the coding properties of O6-methylguanine in DNA: the crucial role of the conformation of the phosphodiester bond. Biochemistry. 1994 May 3;33(17):5335–5346. doi: 10.1021/bi00183a042. [DOI] [PubMed] [Google Scholar]
  32. Tanti J. F., Grémeaux T., Van Obberghen E., Le Marchand-Brustel Y. Insulin receptor substrate 1 is phosphorylated by the serine kinase activity of phosphatidylinositol 3-kinase. Biochem J. 1994 Nov 15;304(Pt 1):17–21. doi: 10.1042/bj3040017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Toker A., Cantley L. C. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature. 1997 Jun 12;387(6634):673–676. doi: 10.1038/42648. [DOI] [PubMed] [Google Scholar]
  34. Vanhaesebroeck B., Higashi K., Raven C., Welham M., Anderson S., Brennan P., Ward S. G., Waterfield M. D. Autophosphorylation of p110delta phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo. EMBO J. 1999 Mar 1;18(5):1292–1302. doi: 10.1093/emboj/18.5.1292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Vanhaesebroeck B., Jones G. E., Allen W. E., Zicha D., Hooshmand-Rad R., Sawyer C., Wells C., Waterfield M. D., Ridley A. J. Distinct PI(3)Ks mediate mitogenic signalling and cell migration in macrophages. Nat Cell Biol. 1999 May;1(1):69–71. doi: 10.1038/9045. [DOI] [PubMed] [Google Scholar]
  36. Vanhaesebroeck B., Welham M. J., Kotani K., Stein R., Warne P. H., Zvelebil M. J., Higashi K., Volinia S., Downward J., Waterfield M. D. P110delta, a novel phosphoinositide 3-kinase in leukocytes. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4330–4335. doi: 10.1073/pnas.94.9.4330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wang Q., Bilan P. J., Tsakiridis T., Hinek A., Klip A. Actin filaments participate in the relocalization of phosphatidylinositol3-kinase to glucose transporter-containing compartments and in the stimulation of glucose uptake in 3T3-L1 adipocytes. Biochem J. 1998 May 1;331(Pt 3):917–928. doi: 10.1042/bj3310917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Waugh M. G., Lawson D., Tan S. K., Hsuan J. J. Phosphatidylinositol 4-phosphate synthesis in immunoisolated caveolae-like vesicles and low buoyant density non-caveolar membranes. J Biol Chem. 1998 Jul 3;273(27):17115–17121. doi: 10.1074/jbc.273.27.17115. [DOI] [PubMed] [Google Scholar]
  39. Woscholski R., Dhand R., Fry M. J., Waterfield M. D., Parker P. J. Biochemical characterization of the free catalytic p110 alpha and the complexed heterodimeric p110 alpha.p85 alpha forms of the mammalian phosphatidylinositol 3-kinase. J Biol Chem. 1994 Oct 7;269(40):25067–25072. [PubMed] [Google Scholar]
  40. Wymann M. P., Pirola L. Structure and function of phosphoinositide 3-kinases. Biochim Biophys Acta. 1998 Dec 8;1436(1-2):127–150. doi: 10.1016/s0005-2760(98)00139-8. [DOI] [PubMed] [Google Scholar]
  41. Yu J., Zhang Y., McIlroy J., Rordorf-Nikolic T., Orr G. A., Backer J. M. Regulation of the p85/p110 phosphatidylinositol 3'-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Mol Cell Biol. 1998 Mar;18(3):1379–1387. doi: 10.1128/mcb.18.3.1379. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES